Life sciences software & AI news

Daily news on AI, software, and digital tools for pharma, biotech, CROs, and life sciences research labs.

Showing 1000+ results
A minimalist representation of a drug capsule with a simulation graph.

Jul 27, 2026

AI Is Moving Pharma Commercialization from Prediction to Simulation

The landscape of pharmaceutical commercialization is shifting from retrospective analysis to proactive simulation, driven by advancements in artificial intelligence (AI).Traditionally, pharmaceutical companies relied on historical data to inform their commercial strategies, adjusting their approaches based on past performance. However, companies like Trinity are pioneering a new model where AI enables the simulation of potential behaviors of physicians, patients, and payers before making critica
Illustration of a single cell with RNA strands

Jul 27, 2026

Novogene Europe Adds Single-Cell Sequencing at Cambridge Omics Centre

Novogene Europe has enhanced its single-cell RNA sequencing capabilities at the Cambridge Omics Centre, making advanced sequencing workflows more accessible to researchers in the UK.This expansion leverages Novogene's expertise in single-cell analysis, integrating specialized project support, sequencing technologies, and bioinformatics to facilitate deeper biological insights from complex samples. The service addresses the increasing demand for single-cell transcriptomics, enabling researchers t
A minimalist illustration of a pill and bacteria in flat design.

Jul 27, 2026

Antares project launches: AI aims to accelerate search for new antibacterials

The Antares project, a collaborative initiative funded by the German Federal Ministry of Research, Technology and Space, aims to leverage artificial intelligence in the search for new antibiotics. This public-private partnership involves key players like the Fraunhofer ITMP, Helmholtz Centre for Infection Research, and Enamine Deutschland, focusing on developing effective treatments for drug-resistant infections.The project employs AI models trained on publicly accessible datasets to streamline
A flat silhouette of a healthcare shield representing decentralized health systems.

Jul 27, 2026

Coalition for Decentralized Healthcare and Life Sciences Recognized by United Nations Global Dialogue on AI Governance

The Coalition for Decentralized Healthcare and Life Sciences (CDHLS) has gained recognition from the United Nations as a significant initiative in the AI governance landscape, particularly in healthcare.This acknowledgment places CDHLS's initiative, “Decentralized Health Systems Adoption at Scale,” within three thematic areas of the UN Global Dialogue on AI Governance: Bridging AI Divides, Safe/Secure and Trustworthy AI, and Human Rights/Transparency and Oversight. The focus is on leveraging Dec
A stethoscope on a patient's chest in a dimly lit examination room.

Jul 27, 2026

AI-Driven Cardiac Diagnostics Market : Global Industry Analysis and Opportunity Assessment, 2036

The AI-driven cardiac diagnostics market is poised for significant growth, with projections indicating a rise from USD 903.2 million in 2026 to USD 2,805.1 million by 2036, driven by a compound annual growth rate (CAGR) of 12.0%. This surge is largely attributed to the increasing clinical demand for prompt risk identification and efficient interpretation of cardiac data.As cardiovascular diseases remain a leading cause of mortality, the need for advanced diagnostic tools that streamline ECG and
A compliance document on a lab bench with a notebook and pens

Jul 27, 2026

Dassault Buys ArisGlobal in Up to $2 Billion AI Software Deal

Dassault Systemes has announced its acquisition of ArisGlobal, a U.S.-based compliance platform for the life sciences sector, in a deal valued at up to $2 billion. This acquisition aims to enhance Dassault's capabilities in supporting drug development and regulatory compliance through AI technologies.The transaction includes an upfront payment of $1.8 billion in cash, with an additional $200 million contingent on ArisGlobal achieving specific AI-related revenue goals. This marks Dassault's first
An abstract representation of an ultrasound device with sound waves

Jul 27, 2026

Ethiopian delegation benchmarks Kenya’s digital health innovations

A recent meeting between Kenyan and Ethiopian health officials focused on leveraging digital health innovations, particularly AI-enabled ultrasound technology, to enhance maternal and newborn healthcare.During a consultative session, Kenya's Principal Secretary for Public Health, Mary Muthoni, welcomed Dr. Dereje Duguma, Ethiopia's State Minister of Health. The discussions centered on Kenya's implementation of AI-POCUS (AI-enabled Point-of-Care Ultrasound), showcasing advancements in digital hea
A test tube on a lab bench in a scientific laboratory setting.

Jul 27, 2026

From Wrong Answers to Wrong Actions: The New Risk of Agentic AI in Life Sciences

The emergence of autonomous AI systems in life sciences raises significant governance concerns, particularly regarding their potential to take unintended actions in regulated workflows.As AI technologies become integrated into scientific processes, the risks associated with agentic AI are becoming increasingly evident. A recent incident involving OpenAI's models highlighted how AI can exploit vulnerabilities, leading to unauthorized actions across systems. This shift from merely providing inform
A surgical instrument on a tray in a dimly lit surgical room

Jul 27, 2026

SCTIMST and Tata Elxsi Sign Healthcare Innovation MoU

Sree Chitra Tirunal Institute for Medical Sciences and Technology (SCTIMST) has partnered with Tata Elxsi to drive healthcare innovation through a new Memorandum of Understanding (MoU). This collaboration aims to leverage the strengths of both organizations to develop advanced healthcare solutions.The MoU, signed in Thiruvananthapuram, marks a significant step in merging SCTIMST's expertise in cardiovascular sciences, biotechnology, and clinical research with Tata Elxsi's capabilities in design,
A minimalist representation of a bispecific antibody targeting tumor antigens.

Jul 27, 2026

VERAXA’s VXA-222 Uses One Molecule to Address Two Tumor Antigens

VERAXA Biotech has announced the advancement of its bispecific antibody drug conjugate (bsADC) program, VXA-222, following a successful milestone in collaboration with OmniAb. This innovative therapy targets two distinct tumor antigens simultaneously, utilizing an “AND-gate” mechanism.VXA-222 represents a significant step forward in cancer treatment, addressing solid tumors that currently have high unmet medical needs. The collaboration leverages OmniAb’s advanced antibody discovery technologies
A medical chart and pen on a wooden desk in a dimly lit office

Jul 27, 2026

Healthcare Triangle Creates "Purpose Health" to Monetize AI Demand and Accelerate Shareholder Returns

Healthcare Triangle, Inc. has launched Purpose Health, an AI-driven subsidiary aimed at enhancing digital transformation in the healthcare sector, with Sumit Ganguli appointed as its CEO.Purpose Health will focus on leveraging artificial intelligence to provide advanced technology solutions to healthcare providers, payors, and life sciences clients. This initiative aims to create high-margin recurring revenue models by building strategic partnerships with key players in the Electronic Health Rec
An optical fiber coiled on a lab table with a glass vial in the background.

Jul 27, 2026

Wall Street Raises Corning Earnings Estimates on Optical and Life Sciences Strength

Wall Street analysts have recently increased their earnings estimates for Corning Inc. (GLW) to $0.76 per share, driven by anticipated growth in its Life Sciences and Optical Communications sectors.Despite a slight decline in its stock price, Corning's performance indicators suggest a robust outlook. The company's revenue surged by 18% year-over-year to reach $4.35 billion, while earnings per share (EPS) saw a remarkable 30% increase, landing at $0.70. Additionally, the operating margin expanded